Real-World Burden of Generalized Pustular Psoriasis in a French Observational Study: Prevalence, Incidence, Healthcare Resource Utilization, Comorbidities, Treatment Use, and Mortality
HCRU, costs, and comorbidities with GPP were often double those for comparator cohorts, and mortality was higher. These findings highlight the need to use GPP-targeted treatments that improve patient outcomes and may reduce the burden on healthcare systems.
Authors
- Manuelle Anne Viguier
- Christian Kromer (ORCID: https://orcid.org/0000-0003-2197-4907)
- Maja Mockenhaupt (ORCID: https://orcid.org/0000-0002-6596-1684)
- Nichiren Pillai
- Alice B. Gottlieb
- Marie Najean
- Bhargav Lakshminarasimhan
- Laurent Misery
- Denis Jullien
- Shah Alam Khan
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Boehringer Ingelheim (Germany) (DE)
- University Medical Center Freiburg (DE)
- Southwestern Medical Center (US)
- Hospices Civils de Lyon (FR)
- Centre Hospitalier Universitaire de Reims (FR)
- Universitätsmedizin Göttingen (DE)
- Hôpital Robert-Debré (FR)
- Centre Hospitalier Régional Universitaire de Brest (FR)
- Centre International de Recherche en Infectiologie (FR)
- Southwestern Medical Center (US)
- The University of Texas Southwestern Medical Center (US)
- Université de Reims Champagne-Ardenne (FR)
Publication Details
- Journal
- Dermatology and Therapy
- Published
- 2026-03-08
- DOI
- https://doi.org/10.1007/s13555-026-01691-4
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00